Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Atlanta Braves Holdings Series B
BATRK
$3.28B
| $493K | ﹤0.01% |
17,760
-9,056
| -34% | -$249K |
|
|
HEES
3252
DELISTED
H&E Equipment Services
HEES
| $491K | ﹤0.01% |
+19,547
| New | +$514K |
|
3253
Spectrum Brands
SPB
$2.03B
| $491K | ﹤0.01% |
8,963
-258,206
| -97% | -$13.8M |
|
3254
Xenon Pharmaceuticals
XENE
$6.1B
| $491K | ﹤0.01% |
48,286
-97,096
| -67% | -$823K |
|
|
RVNC
3255
DELISTED
Revance Therapeutics, Inc.
RVNC
| $491K | ﹤0.01% |
31,158
-360,391
| -92% | -$6.25M |
|
|
BMTC
3256
DELISTED
Bryn Mawr Bank Corp
BMTC
| $491K | ﹤0.01% |
+13,602
| New | +$515K |
|
3257
Carlisle Companies
CSL
$13.5B
| $489K | ﹤0.01% |
3,984
-1,631
| -29% | -$188K |
|
3258
Travelzoo
TZOO
$76.7M
| $488K | ﹤0.01% |
+36,429
| New | +$483K |
|
|
FNHC
3259
DELISTED
FedNat Holding Company Common Stock
FNHC
| $487K | ﹤0.01% |
30,362
+4,849
| +19% | +$88K |
|
3260
Gildan
GIL
$9.49B
| $486K | ﹤0.01% |
13,525
-540,382
| -98% | -$18.5M |
|
3261
PUT
LivaNova
LIVN
$4.47B
| $486K | ﹤0.01% |
5,000
| – | – |
|
3262
CALL
Transocean
RIG
$5.48B
| $485K | ﹤0.01% |
+55,700
| New | +$477K |
|
3263
Sunrun
RUN
$2.26B
| $484K | ﹤0.01% |
34,402
-2,911,923
| -99% | -$40.1M |
|
3264
Tucows
TCX
$104M
| $484K | ﹤0.01% |
+5,962
| New | +$434K |
|
|
VIVO
3265
DELISTED
Meridian Bioscience Inc
VIVO
| $484K | ﹤0.01% |
27,456
+2,626
| +11% | +$43.7K |
|
|
NEE.PRR
3266
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $484K | ﹤0.01% |
+7,818
| New | +$469K |
|
|
MSL
3267
DELISTED
Midsouth Bancorp, Inc.
MSL
| $483K | ﹤0.01% |
42,350
-10,523
| -20% | -$118K |
|
3268
NI Holdings
NODK
$320M
| $482K | ﹤0.01% |
30,110
-11,274
| -27% | -$174K |
|
3269
CALL
VanEck Oil Services ETF
OIH
$1.97B
| $482K | ﹤0.01% |
1,400
-4,405
| -76% | -$1.49M |
|
|
AXAS
3270
DELISTED
Abraxas Petroleum Corp
AXAS
| $482K | ﹤0.01% |
19,289
+2,536
| +15% | +$64.1K |
|
3271
Chunghwa Telecom
CHT
$33.5B
| $480K | ﹤0.01% |
+13,506
| New | +$470K |
|
3272
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
| $480K | ﹤0.01% |
+6,500
| New | +$480K |
|
3273
WIX.com
WIX
$2.56B
| $478K | ﹤0.01% |
3,953
-143,579
| -97% | -$15.6M |
|
3274
Aurinia Pharmaceuticals
AUPH
$1.95B
| $477K | ﹤0.01% |
+73,424
| New | +$487K |
|
3275
Berkshire Hathaway Class B
BRK.B
$1.1T
| $477K | ﹤0.01% |
2,372
-609,812
| -100% | -$123M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.